Obsidian Therapeutics
Obsidian Therapeutics is seeking a Senior Engineer, MSAT to support the manufacturing of critical materials for engineered autologous cell therapies. This role serves as the technical bridge between development and external manufacturing, overseeing technology transfer, risk assessments, and process validation for regulatory approval. The position involves collaborating with cross-functional teams and CDMO partners to ensure manufacturing readiness and operational excellence.
Headquarters
Cambridge, Massachusetts, United States
Obsidian Therapeutics is a clinical-stage biotechnology company using its proprietary cytoDRiVE® platform to engineer novel TIL (tumor-infiltrating lymphocyte) cell therapies. The platform leverages drug-responsive domains (DRDs) to regulate protein function using an FDA-approved small-molecule drug. The company's lead program, OBX-115 (amsoki-cel), is being evaluated in advanced melanoma in a Phase 1/2 clinical trial.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Obsidian Therapeutics.